ThinkWell’s Post

Our ThinkWell Kenya team recently visited Kenya's Principal Secretary of Medical Services, Dr. Ouma Oluga to discuss Cervical Cancer elimination efforts in Kenya. ThinkWell is supporting the MOH to develop the cervical cancer elimination action plan. We discussed the government's plans to switch from a 2 dose to a 1 dose vaccine, as per WHO and KENITAG guidance. ThinkWell looks forward to this switch, which is anticipated to save US$21.4 Million over the first five years, which could potentially fund 2.75 million supplemental HPV vaccinations. This can further increase vaccine coverage from the current 18%, against Kenya’s target of 90%. The HPV vaccine is highly cost effective against preventing cervical cancer, the leading cause of cancer deaths among women in Kenya. Joining us were colleagues from National Cancer Control Program - Kenya and Gates Foundation. Special thanks Dr. Anne Musuva-Njoroge; Murira Felix; Dr Valerian Mwenda; Maureen K.; and Beatrice Ochieng, DrPH, MPH, BSc.